GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0007215 |
None
|
APP, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.90983 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA12, CA2, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1B1, F3, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HSD17B1, HSD17B2, HSD17B3, KDR, MAOA, MET, MIF, SLC1A1, SRC, TNKS, TNKS2, XDH |
7.75189 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, GRM1, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PTPN1, RELA, SRC, TNKS, TNKS2, XDH |
7.75189 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, GRM1, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PTPN1, RELA, SRC, TNKS, TNKS2, XDH |
7.75189 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FDPS, FUT7, HSD17B1, HSD17B2, HSD17B3, MET, MIF, PTGES |
7.15951 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AR, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, GLO1, GRIK5, IGF1R, KDR, MAP2K1, MET, MIF, MMP9, PIM1, PTPN1, RELA, SRC, TOP2A, XDH |
6.93902 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PTPN1, RELA, SRC, TNKS, TNKS2, XDH |
6.44276 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AR, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, GLO1, GRIK5, IGF1R, KDR, MAP2K1, MET, MIF, MMP9, PIM1, PTPN1, RELA, SRC, TOP2A, XDH |
6.38822 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PTPN1, RELA, SRC, TNKS, TNKS2, XDH |
6.38139 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AR, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, GLO1, GRIK5, IGF1R, KDR, MAP2K1, MIF, MMP9, PIM1, PTPN1, RELA, SRC, TOP2A, XDH |
6.38139 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, APP, AR, AXL, CSNK2A1, CYP1B1, F3, FLT3, GRM1, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PTPN1, RELA, SRC, TNKS, TNKS2, XDH |
6.36027 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, PTGES, RELA, SRC |
6.34749 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, CA1, CSNK2A1, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MAP3K7, MET, MIF, MMP2, MMP9, PTPN1, RELA, SRC, TNKS, TNKS2 |
6.31345 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FDPS, FUT7, GLO1, HSD17B3, MIF, PIM1, PTGES, TYR, XDH |
6.19756 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AR, AXL, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, GRIK5, GRM5, HSD17B2, IGF1R, MMP2, MMP9, PTGES, RELA, RORC, SRC, TYR |
6.19756 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FDPS, HSD17B1, HSD17B2, HSD17B3 |
6.19756 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, AR, CDC25B, CSNK2A1, CYP1B1, F3, FABP3, FLT3, IGF1R, KDR, MAP2K1, MIF, MMP12, MMP2, MMP9, PIM1, PTGES, RELA, SRC, XDH |
5.87837 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, F3, FABP3, FLT3, GRIK5, GRM1, GRM5, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, RELA, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
5.87711 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AR, AXL, CYP1B1, F3, FLT3, GRM1, KDR, MAP2K1, MAP3K7, MET, MIF, PTPN1, RELA, SRC, XDH |
5.70632 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, RELA, RORC, SLC1A1, SRC, TNKS, TNKS2, TOP2A, XDH |
5.52014 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, APEX1, APP, AR, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD17B2, IGF1R, KDR, MMP2, PTGES, RELA, RORC, SRC, TYR |
5.00645 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AR, AXL, CSNK2A1, CYP1B1, F3, FABP4, FLT3, GRM1, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP2, MMP9, PTPN1, RELA, SRC, TNKS, TNKS2, XDH |
4.99105 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.96227 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, TYR |
4.87576 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, GLO1, IGF1R, KDR, MET, MIF, MMP9, PIM1, PTPN1, RELA, SRC |
4.83746 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, APEX1, APP, AR, AURKB, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, GRIK5, GRM1, GRM5, IGF1R, KDR, MAP2K1, MAP3K7, MIF, MMP2, MMP9, PTPN1, RELA, RORC, SRC, TOP2A |
4.70945 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, MIF, PTGES |
4.63045 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, GRM1, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP9, PTPN1, RELA, SRC, XDH |
4.4568 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, MIF, PTGES |
4.44556 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, GRIK5, GRM1, GRM3, GRM5, GRM8 |
4.44439 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, GRIK5, GRM1, GRM3, GRM5, GRM8 |
4.44439 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PTGES, PTPN1, RELA, RORC, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
4.41977 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, GLO1, IGF1R, KDR, MET, MIF, MMP9, PIM1, PTPN1, RELA, SRC |
4.40073 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2, HSD17B3 |
4.40073 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, RELA, SRC |
4.40073 |
[BP] GO:0033993 |
response to lipid
|
AR, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, FABP3, FLT3, HSD17B2, PTGES, RELA, RORC, SRC, TYR |
4.30554 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APEX1, APP, AR, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FLT3, PTGES, RELA, RORC, SRC, TYR |
4.27892 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.25701 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, APP, AR, FLT3, GRM1, KDR, MAP2K1, MAP3K7, MIF, PTPN1, SRC, XDH |
4.25701 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, GLO1, IGF1R, KDR, MIF, MMP9, PIM1, PTPN1, RELA, SRC |
4.25701 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7 |
4.2259 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA2, CACNA1C, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, FUT7, GLO1, HSD17B2, HSD17B3, KDR, MAP2K1, MET, MIF, MMP2, MMP9, PIM1, RELA, RORC, SRC, TNKS2, TOP2A, TYR |
4.1939 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AR, AXL, CYP1B1, GRIK5, GRM5, IGF1R, MMP2, MMP9, RELA, RORC, SRC |
4.13466 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, APP, AR, AXL, CA1, CA2, CACNA1C, CSNK2A1, CYP1B1, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP2, MMP9, PIM1, PTGES, PTPN1, RELA, RORC, SRC, TNKS, TNKS2 |
4.13319 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, APEX1, APP, AR, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD17B2, IGF1R, KDR, MMP2, MMP9, PTGES, RELA, RORC, SRC, TYR |
4.13319 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2, HSD17B3 |
4.10143 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2, HSD17B3, MAOA, TYR, XDH |
4.0645 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, APEX1, APP, AR, AXL, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, MMP9, RELA, RORC, SRC |
4.00023 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, FLT3, HSD17B2, HSD17B3, KDR, MAP2K1, RELA, SRC, TYR |
3.98961 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA2, CA4, CA7 |
3.86454 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, APEX1, APP, AR, AXL, CYP1A1, CYP1B1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, RELA, RORC, SRC |
3.8594 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, APP, AR, CDC25B, FLT3, GRM1, GRM5, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SRC, XDH |
3.81059 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, APP, AR, CDC25B, FABP3, FLT3, GRM1, GRM5, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SRC, XDH |
3.74001 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, APP, AR, CDC25B, FABP3, FLT3, GRM1, GRM5, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SRC, XDH |
3.74001 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FDPS, FUT7, MET, MIF, PTGES |
3.74001 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP2, PIM1, PTGES, PTPN1, RELA, RORC, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
3.74001 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APEX1, APP, AR, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, F3, GRIK5, GRM5, IGF1R, KDR, MAP2K1, MET, MIF, MMP12, MMP9, PTPN1, SRC |
3.74001 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, FABP3, FABP4, GLO1, GRM3, GRM8, IGF1R, KDR, MAP2K1, MET, MIF, MMP12, MMP9, PIM1, PTGES, PTPN1, RELA, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
3.73134 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, APP, AR, AXL, CACNA1C, CYP19A1, CYP1A2, CYP1B1, F3, FABP4, GRM1, GRM5, GRM8, HSD17B2, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PIM1, RELA, RORC, SRC, TNKS2, TYR |
3.73063 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, APP, AR, CDC25B, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SRC, XDH |
3.72146 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, APP, AR, FLT3, GRM1, IGF1R, KDR, MAP2K1, MAP3K7, MIF, PTPN1, SRC, XDH |
3.69417 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, APP, AR, CDC25B, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SRC, XDH |
3.67852 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, APP, AR, CDC25B, FLT3, GRM1, GRM5, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SRC, XDH |
3.63889 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, MIF, PTGES |
3.58014 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HSD17B2, IGF1R, KDR, MAP2K1, MAP3K7, MIF, MMP12, MMP2, MMP9, PTGES, PTPN1, RELA, RORC, SRC, TOP2A, TYR |
3.5715 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CBR1, CYP1A1, CYP1A2, CYP1B1, PTGES |
3.53116 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, CDC25B, FABP4, FLT3, GRM1, GRM5, IGF1R, MAP2K1, MAP3K7, MIF, PTPN1, SRC, TNKS |
3.52683 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, APP, AR, AURKB, CDC25B, CSNK2A1, F3, FLT3, GRM1, GRM5, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PTPN1, RELA, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
3.51812 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AR, CDC25B, CSNK2A1, F3, FLT3, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1, RELA |
3.51594 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1B1, FDPS, HSD17B3, MAOA, TYR |
3.51594 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.50942 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APEX1, APP, CACNA1C, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MIF, MMP9, SRC |
3.47506 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MIF, MMP9, SRC |
3.42028 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, GRM1, GRM3, GRM5, GRM8 |
3.39097 |
[BP] GO:0035235 |
None
|
APP, GRIA2, GRIA4, GRIK5 |
3.38875 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, RELA, SRC |
3.38655 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CACNA1C, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PTGES, PTPN1, RELA, RORC, SLC1A1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
3.37369 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APEX1, APP, AXL, CA12, CA2, CA7, CACNA1C, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, MET, SRC |
3.37369 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, CDC25B, FABP4, FLT3, GRM1, GRM5, IGF1R, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
3.35814 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, RELA |
3.35814 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2, HSD17B3 |
3.35814 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, RELA, SRC |
3.35814 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, FLT3, GRM1, IGF1R, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
3.35387 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA7, CACNA1C, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F3, FABP3, FABP4, FDPS, FLT3, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PTGES, PTPN1, RELA, RORC, SLC1A1, SRC, TNKS, TNKS2, TOP2A, XDH |
3.35387 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, FDPS, HSD17B1, HSD17B2, HSD17B3, MIF, PTGES |
3.34527 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, APP, AR, CDC25B, FABP4, FLT3, GRM1, GRM5, IGF1R, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SRC, XDH |
3.34527 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TNKS |
3.33667 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, APP, AR, AURKB, CDC25B, F3, FABP3, FLT3, GRM1, GRM5, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PTPN1, RELA, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
3.33516 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AR, AURKB, CDC25B, CSNK2A1, F3, FLT3, GRM1, GRM5, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PTPN1, RELA, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
3.29957 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, CDC25B, FLT3, GRM1, GRM5, MAP2K1, MAP3K7, MIF, PTPN1, SRC, TNKS |
3.28477 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, FLT3, GRM1, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
3.26225 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, APP, AR, AURKB, CDC25B, CSNK2A1, F3, FABP3, FLT3, GRM1, GRM5, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PTPN1, RELA, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
3.26225 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, APP, AR, AURKB, CDC25B, F3, FLT3, GRM1, GRM5, MAP2K1, MAP3K7, MET, MIF, MMP9, PTPN1, RELA, SRC, TNKS, XDH |
3.25942 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
3.253 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MIF, MMP9, SRC |
3.253 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR, RELA |
3.2477 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AR, AURKB, CDC25B, CSNK2A1, F3, FABP4, FLT3, GRM1, GRM3, GRM5, IGF1R, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SRC, TNKS, XDH |
3.2477 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
3.2247 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1, HSD17B3 |
3.20289 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, CACNA1C, KDR, MIF, SRC, TNKS, TNKS2 |
3.16143 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, RELA, SRC |
3.16143 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, APEX1, APP, AR, CA2, CSNK2A1, CYP1A2, FABP3, FLT3, GRM5, IGF1R, MMP2, RELA, SRC |
3.16143 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, FDPS, HSD17B1, HSD17B2, HSD17B3 |
3.14743 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.14671 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, CDC25B, FABP4, FLT3, GRM1, GRM5, IGF1R, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
3.14671 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, APP, AR, CDC25B, CSNK2A1, F3, FLT3, GRM1, GRM5, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, RELA, SRC, XDH |
3.14671 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
3.14671 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.14671 |
[BP] GO:0007193 |
None
|
ADORA1, GRM1, GRM3, GRM5, GRM8 |
3.03886 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, MAOA, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
3.01884 |
[BP] GO:0060078 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5, GRM5 |
3.01721 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APEX1, APP, GRM5, IGF1R, RELA, SRC |
3.0078 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, MIF, PTGES |
2.98901 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, FABP3, FABP4, GLO1, GRM3, GRM8, IGF1R, KDR, MAP2K1, MET, MIF, MMP12, MMP9, PIM1, PTGES, PTPN1, RELA, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
2.97766 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, APP, AR, CDC25B, FABP4, FLT3, GRM1, GRM5, IGF1R, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SRC, XDH |
2.97766 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MIF, MMP9, SRC |
2.96592 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2, HSD17B3 |
2.96251 |
[BP] GO:0042391 |
None
|
ADORA1, APP, CACNA1C, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
2.95748 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APEX1, APP, AR, AURKB, AXL, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PTGES, PTPN1, RELA, RORC, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
2.9456 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, CDC25B, FLT3, GRM1, GRM5, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
2.93433 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, GRM5, MIF |
2.91617 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APEX1, APP, AR, AURKB, AXL, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PTGES, PTPN1, RELA, RORC, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
2.8987 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AR, AXL, CA2, CYP1B1, F3, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PIM1, RELA, SLC1A1, SRC |
2.89219 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, APP, AR, CDC25B, FLT3, GRM1, GRM5, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SRC, XDH |
2.89219 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.84572 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, GRM1, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PTPN1, RELA, SRC, TNKS, TNKS2, XDH |
2.84478 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, CYP1A1, FLT3, MAP2K1, MET, MIF, PIM1, SRC, TYR |
2.84077 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, PTGES, RELA, SRC |
2.7867 |
[BP] GO:0050730 |
None
|
ADORA1, APP, FLT3, GRM5, MIF, PTPN1, SRC |
2.78044 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, CDC25B, FLT3, GRM1, GRM5, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
2.74269 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, APP, AR, CDC25B, FABP4, FLT3, GRM1, GRM5, IGF1R, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, RELA, SRC, XDH |
2.71325 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, APEX1, APP, AURKB, AXL, CDC25B, CSNK2A1, FDPS, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, PTPN1, SRC, TNKS, XDH |
2.69446 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1B1, F3, FABP4, FLT3, GRM1, GRM3, GRM5, IGF1R, MAP2K1, MAP3K7, MET, MIF, MMP9, PIM1, PTPN1, RELA, SRC, TNKS, XDH |
2.6363 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, APP, AXL, CYP1B1, MMP9, RELA, SRC |
2.62012 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CYP19A1, F3, FABP4, IGF1R, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP2, PTPN1, RELA, SRC, XDH |
2.5938 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, APP, FABP3, GRM5, IGF1R, RELA, SRC |
2.57849 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CBR1, CYP1A1, CYP1A2, CYP1B1, PTGES |
2.57818 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, FLT3, GRM1, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
2.56799 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APEX1, APP, AR, CYP1A1, CYP1B1, FLT3, RORC, SRC |
2.56799 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.5435 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TNKS |
2.54318 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, FLT3, GRM5, MIF, PTPN1, SRC |
2.5272 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, MAP3K7, PIM1, RELA, RORC, SRC |
2.50142 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, FABP4, GRM3, IGF1R, MET, MMP9, PIM1, PTPN1, SRC, TNKS |
2.4946 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, APEX1, APP, AURKB, AXL, CDC25B, CSNK2A1, FDPS, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, PTPN1, SRC, TNKS, XDH |
2.46066 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, FDPS |
2.46066 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.46066 |
[BP] GO:0032787 |
None
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, MIF, PTGES |
2.45649 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AR, AXL, CA2, CACNA1C, CYP1B1, F3, GRM1, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PIM1, RELA, SLC1A1, SRC, TNKS2, XDH |
2.44061 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, SRC, TNKS, TOP2A |
2.44061 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.4349 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.4349 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, CYP19A1, HSD17B2, HSD17B3, MAP2K1, SRC |
2.4349 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.4349 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, APP, AR, CDC25B, F3, FLT3, GRM1, GRM5, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SRC, XDH |
2.41089 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, F3, FABP3, FABP4, FDPS, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PIM1, PTPN1, RELA, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
2.36144 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.34889 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, APP, FABP3, FLT3, GRM5, IGF1R, MMP2, RELA, SRC, TYR |
2.34405 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, KDR, RELA, SRC |
2.33147 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, FLT3, GRM1, IGF1R, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
2.32832 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, APEX1, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1A1, CYP1B1, F3, FABP3, FABP4, FDPS, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PIM1, PTPN1, RELA, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
2.32792 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.31849 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.2956 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, APP, GRM5, IGF1R, MMP2, RELA, SRC |
2.27688 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1A1, CYP1B1, KDR, RELA, SRC |
2.22938 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, APP, AURKB, CDC25B, F3, FLT3, GRM1, GRM5, MAP2K1, MAP3K7, MIF, PTPN1, SRC, TNKS, XDH |
2.22461 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.21443 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, APP, AR, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, F3, FLT3, FUT7, GLO1, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, RELA, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
2.21202 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, FDPS |
2.20777 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.20777 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, CA12, CA2, CA7, CACNA1C, FABP3, FABP4, GRIK5, GRM1, GRM5, MET |
2.20211 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, APEX1, AR, CA2, CSNK2A1, CYP1A2, FABP3, FLT3, RELA, SRC |
2.20211 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.20211 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.20211 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.20211 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.19845 |
[BP] GO:0006081 |
None
|
AKR1B10, CYP1B1, GLO1, RELA |
2.19845 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APEX1, APP, AR, AURKB, CSNK2A1, FABP4, GRM3, GRM8, IGF1R, KDR, MAP2K1, MET, MIF, MMP12, MMP9, PTPN1, RELA, RORC, SRC, TNKS, TNKS2, XDH |
2.19845 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.18811 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, CACNA1C, KDR, SRC |
2.18614 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, APP, AR, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, HSD17B2, HSD17B3, KDR, MAP2K1, MMP9, PIM1, RELA, RORC, SRC, TYR |
2.16436 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, MIF, MMP9, PTPN1, RELA, SRC |
2.15727 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.15455 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.14755 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, MAP3K7, MET, MMP2, MMP9, PTPN1, SRC |
2.14198 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, IGF1R, MAP2K1, MAP3K7, PTPN1, XDH |
2.1195 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, APP, FABP3, FLT3, GRM5, IGF1R, MMP2, RELA, SRC, TYR |
2.11883 |
[BP] GO:0060079 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5 |
2.11883 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, F3, FABP4, FLT3, GRM1, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP2, MMP9, PTPN1, RELA, SRC, TNKS, TNKS2, XDH |
2.11883 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, IGF1R, MAP2K1, MAP3K7, PTPN1, XDH |
2.11549 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, APP, AR, FLT3, GRM5, IGF1R, MMP2, RELA, SRC |
2.10657 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.10657 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, APP, GRM5, IGF1R, MMP2, RELA, SRC |
2.10104 |
[BP] GO:0010038 |
response to metal ion
|
APP, CA2, CYP1A1, CYP1A2, FABP4, MMP9, PTGES |
2.07887 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.06509 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
APP, GRM5, IGF1R |
2.06509 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.04184 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX5, CYP19A1, CYP1A1, FDPS, HSD17B3, MIF, PTGES |
2.03675 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
CYP19A1, HSD17B3 |
2.0309 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.0309 |
[BP] GO:0061097 |
None
|
ADORA1, APP, GRM5, PTPN1 |
2.02554 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.35387 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.35272 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, APP, CACNA1C, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SRC |
3.25049 |
[CC] GO:0014069 |
None
|
ADORA1, CACNA1C, GRIK5, GRM1, GRM3, GRM5, SRC |
3.13239 |
[CC] GO:0099572 |
None
|
ADORA1, CACNA1C, GRIK5, GRM1, GRM3, GRM5, SRC |
3.13239 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APEX1, APP, AR, AURKB, CA1, CA2, CA4, CA7, CACNA1C, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, GRIA2, GRIA4, GRIK5, HSD17B1, HSD17B2, HSD17B3, KDR, MAOA, MAP2K1, MAP3K7, MIF, MMP2, MMP9, PIM1, PTGES, PTPN1, RELA, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
3.1279 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, APEX1, APP, AR, AURKB, AXL, CA1, CA2, CA4, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, GRIA4, GRIK5, GRM1, GRM5, HSD17B3, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MIF, MMP12, MMP2, MMP9, PIM1, PTPN1, RELA, RORC, SHBG, SLC1A1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
2.913 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, APP, AR, AXL, CA12, CA2, CA4, CACNA1C, CSNK2A1, F3, FLT3, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP2, PIM1, PTPN1, SLC1A1, SRC |
2.85684 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX5, APP, AR, AXL, CA12, CA2, CA4, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F3, FLT3, FUT7, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD17B2, HSD17B3, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP2, PIM1, PTGES, PTPN1, SLC1A1, SRC, TNKS, TNKS2, TYR |
2.84478 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, CA2, CA4, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, MET, SLC1A1, SRC |
2.61578 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, CA4, F3, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, SLC1A1 |
2.58045 |
[CC] GO:0043226 |
organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, APEX1, APP, AR, AURKB, AXL, CA1, CA2, CA4, CACNA1C, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, GRIA4, GRIK5, GRM1, GRM3, GRM5, HSD17B3, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MIF, MMP12, MMP2, MMP9, PIM1, PTPN1, RELA, RORC, SHBG, SLC1A1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
2.53082 |
[CC] GO:0043197 |
None
|
ADORA1, APP, GRIA2, GRIA4, GRM3 |
2.30359 |
[CC] GO:0097060 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
2.2956 |
[CC] GO:0044309 |
None
|
ADORA1, APP, GRIA2, GRIA4, GRM3 |
2.27686 |
[CC] GO:0005783 |
None
|
ADORA1, APEX1, APP, CA4, CYP19A1, FLT3, GRIK5, HSD17B3, KDR, MAP2K1, PTPN1, XDH |
2.20777 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, APP, AR, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, RORC, TNKS, TYR, XDH |
8.26853 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APEX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F3, FDPS, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PTGES, PTPN1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
7.9892 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.79432 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F3, FABP3, FABP4, FDPS, FLT3, GLO1, HSD17B1, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTGES, PTPN1, RELA, RORC, SLC1A1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
6.51823 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA2, CA4, CA7 |
5.95117 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2, HSD17B3, MAOA, TYR, XDH |
4.96227 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA2, CA4, CA7 |
4.10143 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, CBR1, HSD17B1, HSD17B2, HSD17B3, XDH |
3.86454 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA7, GLO1, MMP1, MMP12, MMP2, MMP9, PTPN1, RORC, TNKS |
3.83278 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.54349 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, APEX1, APP, AR, AURKB, CA1, CA12, CA2, CA4, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FDPS, GLO1, MAP3K7, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, RORC, SLC1A1, TNKS, TNKS2, TOP2A, TYR, XDH |
3.51866 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA2, CA4, CA7 |
3.51594 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.38875 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AR, AXL, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, RORC |
3.35387 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.35272 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AR, AXL, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MAP2K1, MAP3K7, MET, RORC |
3.34264 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, APEX1, APP, AR, AURKB, CA1, CA12, CA2, CA4, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FDPS, GLO1, MAP3K7, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, RORC, SLC1A1, TNKS, TNKS2, TOP2A, TYR, XDH |
3.33667 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
3.29986 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA2, CA4, CA7, GLO1 |
3.26437 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HSD17B1, HSD17B2, HSD17B3 |
3.253 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.97766 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, HSD17B1, IGF1R, SHBG |
2.85684 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AR, AXL, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, RORC |
2.84478 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
2.84426 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET |
2.74431 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET |
2.74431 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AR, AXL, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, RORC |
2.69446 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.69446 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
2.68239 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.66645 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, APEX1, CSNK2A1, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PTPN1, RELA, SRC |
2.58045 |
[MF] GO:0030594 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
2.4349 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.4349 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.4349 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.4349 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TOP2A |
2.36118 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
2.24284 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, APEX1, FLT3, IGF1R, KDR, MMP12, MMP9, PTPN1, RELA, SRC |
2.20828 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.20211 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.20211 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.18568 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD17B1, HSD17B2, HSD17B3 |
2.06509 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.06282 |